Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs NiSource Inc Common Stock (NI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs NiSource Inc Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $111.12 (market cap $12.58B), while NiSource Inc Common Stock trades at $40.75 (market cap $19.44B). The key difference: NiSource Inc Common Stock is the larger of the two by market cap, and NiSource Inc Common Stock pays a 2.96% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and NiSource Inc Common Stock for 1 Days on average.
| HALO | NI | |
|---|---|---|
Market Cap | $12.58B | $19.44B |
Volume | 2,179,278 | 3,945,959 |
Sector | Health | Utilities |
52-Week High | $115.22 | $49.08 |
52-Week Low | $61.63 | $39.00 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $36.77B |
Dividend Yield | — | 2.96% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About NiSource Inc Common Stock
NiSource is an energy holding company whose regulated subsidiaries provide natural gas and electricity services. Its business is organized around gas distribution and electric operations in the United States.
Read more on NI →
